Skip to main content

Table 3 Univariable and multivariable analyses of glycolysis-related DEGs

From: The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma

Gene Univariate analysis Multivariable analysis
HR UI of 95%CI LI of 95%CI p-value Coef HR
CD44 1.462 1.254 1.705 1.24E-06 0.239 1.270
PLOD2 1.357 1.165 1.582 9.16E-05 0.203 1.225
KIF20A 1.946 1.634 2.316 7.19E-14 0.695 2.003
IDUA 2.061 1.643 2.586 4.2E-10 0.527 1.695
PLOD1 1.306 1.044 1.633 0.019442 −0.265 0.767
HMMR 1.878 1.486 2.373 1.27E-07 −0.998 0.369
DEPDC1 2.284 1.740 2.997 2.7E-09 0.886 2.426
ANKZF1 1.452 1.189 1.772 0.000248 0.199 1.220
RBCK1 1.925 1.571 2.358 2.65E-10
CAPN5 0.710 0.548 0.918 0.009126
COL5A1 1.332 1.179 1.505 4.25E-06
ISG20 1.695 1.328 2.162 2.17E-05
GAPDH 1.462 1.129 1.892 0.003945
TGFBI 1.127 1.052 1.206 0.000614
AK3 0.578 0.428 0.779 0.000325
ENO2 1.276 1.084 1.502 0.003391
GOT1 0.636 0.525 0.769 3.11E-06
CENPA 2.449 1.956 3.065 5.47E-15
EFNA3 1.391 1.104 1.752 0.005062
HK3 1.763 1.417 2.193 3.63E-07
ALDOB 0.859 0.801 0.921 2.2E-05
MIOX 0.866 0.807 0.929 5.86E-05
TREH 0.687 0.539 0.875 0.00231
  1. DEGs differentially expressed genes, HR hazard ratio, CI confidence interval, UI upper limit, LI lower limit, Coef coefficient